newswire

Novo Nordisk Shares Plunge More Than 10% Before the U.S. Market Open

2026-08-01·newswire-us-stock-002852

Novo Nordisk Shares Plunge More Than 10% Before the U.S. Market Open.

Novo Nordisk shares plunged more than 10% in premarket trading. According to Cailian Press, the company released the latest update on its ZEUS Phase 3 clinical trial.

#Stocks #Markets

Full text

Novo Nordisk Shares Plunge More Than 10% Before the U.S. Market Open

Novo Nordisk shares plunged more than 10% in premarket trading. According to Cailian Press, the company released the latest update on its ZEUS Phase 3 clinical trial.

← Back to archive